📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human ?-Butyrobetaine Hydroxylase (2025)

First Author: Corner T

Attributed to: RapidFire Enhancement of Mass Spectrometry Capability Across the Biosciences funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.5c00586

PubMed Identifier: 40263713

Publication URI: http://europepmc.org/abstract/MED/40263713

Type: Journal Article/Review

Volume: 68

Parent Publication: Journal of Medicinal Chemistry

Issue: 9

ISSN: 0022-2623